Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Times New Jersey.
Press releases published on September 3, 2025
Rail Vision Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
Ra’anana, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, today announced that it has received a …
Radiance Biopharma Signs Exclusive License For ‘First In Class’ c-Met/EGFR Targeted Nano Antibody ADC
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or "Company"), a clinical-stage biotechnology company, announced that it has signed an Exclusive License Agreement with Novatim Immune Therapeutics (Zhejiang) CO., LTD. , (“ …
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Asure Software Sets September 2025 Investor Conference Schedule
AUSTIN, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Asure Software, Inc. (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management (“HCM”) software solutions, is scheduled to participate at the following financial conferences during …
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized …
MOG Digitech Holdings Limited (1942.HK) Makes Strategic Investment in ALT5, Partners with WLFI to Advance Stablecoin and DeFi Ecosystem
Hong Kong, China, Sept. 03, 2025 (GLOBE NEWSWIRE) -- On August 25, MOG Digitech Holdings Limited (1942.HK)(“MOG Digitech”) announced a strategic investment of USD 500,000 in ALT5 Sigma Corporation (NASDAQ: ALTS) (“ALT5”), indirectly through the …
XLM News: Introducing StellarPad AI, Stellar Blockchain's First-Ever Non-Custodial AI Launchpad
HAMILTON, New Zealand, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Stellar Lumens (XLM) community is about to experience a groundbreaking shift as the highly-anticipated StellarPad AI introduces itself to the crypto community. Defined as "The First Non- …
American Botanical Council Debuts Saw Palmetto Educational Video on HerbTV
Austin, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The nonprofit American Botanical Council (ABC) announces the premiere of its new educational video, “Saw Palmetto: Safe and Effective Herb for Prostate and Men’s Urinary Health.” The video is available on …
iDox.ai Launches Comprehensive Redaction Suite for Automated Data Protection
Fremont, California, Sept. 03, 2025 (GLOBE NEWSWIRE) -- iDox.ai, a leader in AI-driven document compliance solutions, today announced the launch of its Redaction Suite, a complete platform designed to automate and streamline the redaction of sensitive …
Lumenix et le centre universitaire de santé McGill travaillent de concert pour rehausser la sécurité des patients et du personnel de soutien par l’entremise d’une technologie de plateforme d’IA perception-action ambiantes
OTTAWA, Ontario, 03 sept. 2025 (GLOBE NEWSWIRE) -- Lumenix annonce aujourd’hui un accord de collaboration pluriannuel pour le déploiement de la plateforme technologique AIMS (Artificially Intelligent Monitoring System) au Centre universitaire de santé …
Michael Carbonara Launches Campaign for Congress
Broward County, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Michael Carbonara, a lifelong conservative and entrepreneur who has started successful businesses in banking, cryptocurrency and fertility care, announced today that he is running for the United States …
374Water to Attend Upcoming Investor Conferences in September
Lake Street 9th Annual Best Ideas Growth (BIG9) Conference, H.C. Wainwright 27th Annual Global Investment Conference, and Gabelli Funds’ 3rd PFAS Symposium DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ: SCWO) (“374Water”) (the “ …
New Study: Gut Health Program Cuts Infant Eczema Odds by 83% in C-Section Babies
AUSTIN, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) -- A new study found that babies born by C-section had 83% lower odds of developing eczema when their families participated in a 6-month gut health support program, compared to those who didn't receive the …
Rackspace Technology ernennt Gajen Kandiah zum Chief Executive Officer
SAN ANTONIO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), ein globaler Anbieter von Hybrid-Cloud- und KI-Lösungen, hat heute bekannt gegeben, dass sein Verwaltungsrat Gajen Kandiah mit Wirkung zum 3. September 2025 zum Chief …
Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
First-ever potentially disease-modifying therapy for uncontrolled Graves’ disease patients Of 21 patients who entered the six-month off-treatment follow-up period, ~80% (17/21) demonstrated response, resulting in normal thyroid function (T3 and T4 less …
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
First-ever potentially disease-modifying therapy for uncontrolled Graves’ disease patients Of 21 patients who entered the six-month off-treatment follow-up period, ~80% (17/21) demonstrated response, resulting in normal thyroid function (T3 and T4 less …
AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem
AlphaTON Capital Unlocks Public Market Access to Toncoin (TON) and Telegram’s Billion-User Ecosystem Brittany Kaiser, pioneer in data protection, digital assets, and the public equity markets appointed Chief Executive Officer and Board Member Formerly …